Bottom Line I.T. with Mike Maddox
and Erik Jacobsen.
RECORDED at ASK May 21 and May 28, 2019.
Bottom Line I.T.
with Mike Maddox and Erik Jacobsen
RECORDED at ASK
May 7 and May 14, 2019
On this episode podcast of Bottom Line I.T. with Amy Mumby and Erik Jacobsen address the latest in I.T. news including Two-Factor Authentication and Aibo's dark side. Take listen for a whole lot more!
Heather Ballien Superintendent, Great Lakes Cyber Academy rejoins the Michigan Business Network to share more about how online schools like Great Lakes Cyber Academy, are preparing students for career readiness in an ever-increasing digital world.
Originally a guest in October 2018, she now also addresses their perspective on a new state budget proposal.
Chris Holman welcomes Kevin Schoen, CEO, ACD.net, Lansing, MI, to the MBN studio where they talk about the history of the company and their connection over the years. Then Kevin re-introduces ACD.net to the Michigan business community.
ACD is a facilities based Internet and Telecommunications provider serving much of Michigan, with its headquarters in Lansing. ACD provides Fiber Optic Service, Metro Ethernet, Telephone, DSL, Datacenter and Web hosting services. They also cover the new service of surveillance/security camera set-ups for businesses.
On this podcast episode of Bottom Line I.T. Erik Jacobsen and Mike Maddox talk about the latest in technology news and some best practices including phishing attacks, the MSP market, tech's talent crisis, and the 773 Million Record "Collection #1" Data Breach.
News Release Provided By Senator Gary Peters
WASHINGTON, DC – U.S. Senators Gary Peters (D-MI), Thom Tillis (R-NC), David Perdue (R-GA), and Kyrsten Sinema (D-AZ) this week introduced the Fostering Innovation Act of 2019,bipartisan legislation that would extend regulatory relief for certain small businesses and startups, including many bio-tech innovators. This industry faces additional burdens when complying with federal regulations due to the nature of the resource-intensive research and development costs associated with providing new scientific and medical developments to consumers.